CDC5L and Myocardial fibrosis: Finally, RT-PCR analysis revealed that the transcript levels ofcol1a1 andcol3a1, which are markers of myocardial fibrosis, were significantly decreased in the CDC5L-overexpressing group; however, this anti-fibrotic effect of CDC5L was largely reversed followingFGF10 knockdown (Figure 7G,H).